Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harkins Kovler is an independent proxy solicitation and strategic advisory firm specializing in shareholder activism, M&A transactions, and proxy contests. Founded in 2015 and headquartered in New York with an office in London, the firm provides services including share ownership analysis, vote projections, and information agent services for tender offers. Harkins Kovler is frequently retained by activist investors and corporations to navigate complex governance and control matters. The firm has a significant presence in the life sciences sector, representing participants in high-profile proxy battles at companies such as Illumina and Athira Pharma. Its expertise includes developing strategic approaches to institutional and retail investors to maximize success in contested situations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harkins Kovler.